Discrimination between complete moles (CMs), partial moles (PMs), and hydropic abortions (HAs) is important as the risk of persistent gestational trophoblastic disease (GTD) differs for each condition. We evaluated whether ancillary fluorescence in situ hybridization (FISH) with a set of chromosome enumeration probes (CEP) for chromosomes X, Y, and 17 and p57 immunostaining could improve the clinical diagnosis. Forty-one products of conception (POC) were reclassified according to clinical performance, morphology, p57 immunostaining results, and FISH results. The accuracy of histological examination alone was 85% for the original diagnosis. FISH analysis showed diploidy in 19 of 20 CMs and triploidy in 4 of 6 PMs. The concordance rate was 92.5% on using the CEP probes. p57 Staining was negative in all CMs and positive in all PMs and HAs. Chromosomal abnormality was detected in 3 cases of HA by using FISH. In conclusion, combined p57 immunostaining and FISH with a set of 3 CEP probes for chromosomes X, Y, and 17 could be useful in the classification of hydatidiform moles.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2014.03.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ethnic disparities in complete and partial molar pregnancy incidence: a retrospective analysis of arab and jewish women in single medical center.
BMC Public Health
May 2024
Department of Obstetrics and Gynecology, Galilee Medical Center, POB 21, 22100, Nahariya, Israel.
Background: Molar pregnancies, encompassing complete and partial moles, represent a rare and enigmatic gestational disorder with potential ethnic variations in incidence. This study aimed to investigate relations of ethnicity with risks of complete and partial molar pregnancies within an Israeli population while accounting for age differences.
Methods: A retrospective study was conducted of data recorded during 2007-2021 in an academic medical center in Israel.
Immunostaining with p57KIP2 is a widely used diagnostic technique to differentiate complete hydatidiform moles (CHMs) from partial hydatidiform moles (PHM) and non-molar hydropic abortion. However, distinguishing between PHMs and non-molar hydropic abortions using histopathology alone is often challenging. This study aimed to evaluate the technical validity and additional benefits of using fluorescence in situ hybridization (FISH) in combination with p57KIP2 immunostaining to diagnose molar and non-molar conceptuses.
View Article and Find Full Text PDFAndrogenetic/biparental mosaicism in a diploid mole-like conceptus: report of a case with triple paternal contribution.
Virchows Arch
November 2023
Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, 69495, Pierre-Benite Cedex, France.
Hydatidiform moles (HMs) are divided into two types: partial hydatidiform mole (PHM) which is most often diandric monogynic triploid and complete hydatidiform mole (CHM) which is most often diploid androgenetic. Morphological features and p57 immunostaining are routinely used to distinguish both entities. Genetic analyses are required in challenging cases to determine the parental origin of the genome and ploidy.
View Article and Find Full Text PDFTiny Hydatidiform Mole Presenting As Pregnancy of Unknown Location.
Cureus
June 2023
Department of Obstetrics and Gynecology, Marunouchi Hospital, Matsumoto, JPN.
Article Synopsis
- Pregnancy of unknown location (PUL) occurs when a pregnancy test is positive, but a pregnancy cannot be confirmed through ultrasound, leading to diagnostic procedures like dilation and curettage (D&C) or laparoscopy.
- A case study highlighted a tiny complete hydatidiform mole discovered during D&C, suggesting that even small abnormal growths in PUL cases should prompt further investigation.
- Further research is needed to determine if these tiny moles pose risks for persistent gestational trophoblastic disease, but D&C may help clarify diagnoses in PUL patients.
When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease.
Gynecol Obstet Invest
June 2024
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Background: Gestational trophoblastic disease comprises hydatidiform moles and a rare group of malignancies that derive from trophoblasts. Although there are typical morphological features that may distinguish hydatidiform moles from non-molar products of conception, such features are not always present, especially at early stages of pregnancy. Furthermore, mosaic/chimeric pregnancies and twin pregnancies make pathological diagnosis challenging while trophoblastic tumours can also pose diagnostic problems in terms of their gestational or non-gestational origin.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!